Current Report Filing (8-k)
14 February 2014 - 9:11AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
____________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): December 10, 2013
REGENICIN,
INC.
(Exact
name of registrant as specified in its charter)
| Nevada
|
|
333-146834 |
|
27-3083341 |
| (State
or other jurisdiction of incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer Identification No.) |
| 10
High Court, Little Falls, NJ 07424 |
| Address
of principal executive offices |
Registrant’s
telephone number, including area code: (646) 403-3581
________________________________________________
(Former
name or former address, if changed since last report) |
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| [ ] |
Written communications pursuant to Rule 425
under the Securities Act (17CFR 230.425) |
| |
|
| [ ] |
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| |
|
| [ ] |
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| [ ] |
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Section
5 - Corporate Governance and Management
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On January
6, 2011, we approved the issuance of options to each of the members of our board of directors. On May 11, 2011, we approved the
amendment of those options to allow immediate vesting. On December 10, 2013, we approved the amendment to those options to change
the exercise price to $0.035 per share. The amended options are described in the table below.
| Name |
Number
of Shares Underlying Option |
Exercise
Price Per Share |
Vesting
Schedule |
Expiration
Date |
| Randall McCoy |
885,672 |
$0.035 |
Immediately |
December 22,
2015 |
| John Weber |
885,672 |
$0.035 |
Immediately |
December 22,
2015 |
| Dr. Craig Eagle |
885,672 |
$0.035 |
Immediately |
December 22,
2015 |
| Dr. Joseph Rubinfeld |
885,672 |
$0.035 |
Immediately |
December 22,
2015 |
The foregoing
description is qualified in its entirety by reference to the full text of the Regenicin, Inc. 2010 Equity Incentive Plan Stock
Option Agreement, as amended, received by each board member, setting forth the terms of the option grant, which form is attached
as Exhibit 10.1 hereto and incorporated by reference herein.
The above
options were granted under the pursuant Regenicin, Inc. 2010 Incentive Plan, which was previously filed as Exhibit 10.1 to our
Current Report on Form 8-K filed with the SEC on December 21, 2010 and incorporated herein by reference.
Section
9 – Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
REGENICIN,
INC.
/s/ Randall
McCoy
Randall
McCoy
CEO and
Director
Date: December
10, 2013
Regenicin (CE) (USOTC:RGIN)
Historical Stock Chart
From Feb 2025 to Mar 2025
Regenicin (CE) (USOTC:RGIN)
Historical Stock Chart
From Mar 2024 to Mar 2025
